Expired Canadian patentCanada
7a5/prognostin and use thereof for the diagnostic and therapy of tumors
CA 2526240 C · Owner: Charite - Universitaetsmedizin Berlin · Inventors: Walther, Wolfgang; Schwabe, Holger; Stein, Ulrike
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to the nucleic acid sequence coding for the , polypeptide of 7a5/prognostin and to the uses thereof, in particular for the , diagnosis and therapy of metastasizing tumors.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 19, 2004 and granted September 16, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 19, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 19, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJuly 19, 2004
GrantedSeptember 16, 2014
Term endedJuly 19, 2024
Patent numberCA 2526240 C
Classification (IPC)C07K14/47 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.